Filtered By:
Infectious Disease: Coronavirus
Countries: Canada Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 34 results found since Jan 2013.
Anxiety in adults with asthma during the coronavirus disease 2019 pandemic: a Canadian perspective
Asthma is a chronic airway inflammatory disease that affects millions of Canadians and often contributes to higher levels of anxiety among patients. Since the coronavirus disease 2019 (COVID-19) pandemic was a...
Source: Allergy, Asthma and Clinical Immunology - August 23, 2023 Category: Allergy & Immunology Authors: Sophia Linton, Kayley Xu, Lubnaa Hossenbaccus, Hannah Botting, Sarah Garvey, Adam Sunavsky, Lisa M. Steacy, Dean A. Tripp and Anne K. Ellis Tags: Research Source Type: research
The COVID-19 virus mutated to outsmart key antibody treatments. Better ones are coming
In 2020, as the COVID-19 pandemic raged and other effective drugs were elusive, monoclonal antibodies (mAbs) emerged as a lifesaving treatment. But now, 3 years later, all the approvals for COVID-19–fighting antibodies have been rescinded in the United States, as mutations of the SARS-CoV-2 virus have left the drugs—which target parts of the original virus—ineffective.
Researchers around the globe are now trying to revive antibody treatments by redesigning them to take aim at targets that are less prone to mutation. “There are new approaches that present a much more challenging task for the virus to evade,” ...
Source: ScienceNOW - May 24, 2023 Category: Science Source Type: news
Eleven science stories likely to make big news in 2023
As the COVID-19 pandemic enters its fourth year as a global health emergency, researchers will continue pushing to help make the disease manageable and ordinary. They will track hundreds of subvariants of Omicron, the highly transmissible but seemingly less lethal strain of SARSCoV-2 that dominated in 2022. Virologists will watch the virus’ evolution this year to see whether it has finally slowed or a more dangerous variant pops up, evading much of the immunity that humanity has built up to previous ones. Vaccine researchers hope to develop new shots that provide broad protection against a variety of coronaviruses. Ano...
Source: ScienceNOW - January 4, 2023 Category: Science Source Type: news
Anxiety in Adults with Allergic Rhinitis During the Coronavirus Disease 2019 Pandemic: A Canadian Perspective
CONCLUSION: High levels of anxiety exist during the COVID-19 pandemic regardless of AR status, indicating the importance of early anxiety screening in all patients. This study also highlights the importance of non-nose/eye symptoms in AR management.PMID:35918024 | PMC:PMC9338449 | DOI:10.1016/j.anai.2022.07.030
Source: Annals of Allergy, Asthma and Immunology - August 2, 2022 Category: Allergy & Immunology Authors: Kayley Xu Sophia Linton Adam Sunavsky Sarah Garvey Hannah Botting Lisa M Steacy Wilma M Hopman Dean A Tripp Anne K Ellis Source Type: research
Lessons from the IMPAACT of coronavirus disease 2019 public health restrictions on food allergy-associated anxiety
Generalized anxiety disorder is among the most common mental health disorder and for which an instrument, the Generalized Anxiety Disorder 7-item scale (GAD-7), has been available to assess this condition for nearly 2 decades.1 During the coronavirus disease 2019 (COVID-19) pandemic, symptoms associated with generalized anxiety disorder have broadly increased, albeit with a disproportionately higher risk among mothers, parents aged 18 to 44 years, those with household incomes less than $100,000 Canadian, or those with certain preexisting mental health conditions, including anxiety.
Source: Annals of Allergy, Asthma and Immunology - July 23, 2022 Category: Allergy & Immunology Authors: Michael A. Golding, Jennifer L.P. Protudjer Tags: Editorial Source Type: research
What to Know About the Latest Advances in Managing Severe Asthma
Graphs and charts don’t always tell the whole story. Numbers can be deceiving. But anyone who looks at U.S. trends in asthma mortality can see, without squinting, that things are moving in the right direction.
A 2019 analysis in the American Journal of Respiratory and Critical Care Medicine found that from 1999 to 2015, asthma mortality fell by 43%. “The decrease in asthma-related mortality was consistent in both sexes and in all race groups, with the largest decrease in patients older than 65 years,” the authors concluded. Figures from the U.S. Centers for Disease Control and Prevention indicate that the...
Source: TIME: Health - June 23, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
Anaphylaxis-related knowledge and concerns in Canadian families during the coronavirus disease 2019 pandemic
Anaphylaxis is a life-threatening condition defined as the involvement of 2 or more systems after exposure to a possible allergen or hypotension after exposure to a known allergen.1-3 The first-line treatment for anaphylaxis is prompt administration of an epinephrine autoinjector (EAI).4 Guidelines advise that after epinephrine administration, patients should arrive to the emergency department (ED) for assessment and observation.2,3 A recent editorial recommends that cases in which symptoms resolve after EAI administration, patients could manage anaphylaxis at home and notify their physician on a nonurgent basis.
Source: Annals of Allergy, Asthma and Immunology - July 11, 2021 Category: Allergy & Immunology Authors: Sofianne Gabrielli, Jennifer L.P. Protudjer, Gregory Gooding, Jennifer Gerdts, Moshe Ben-Shoshan Tags: Letters Source Type: research
Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada
The coronavirus disease 2019 pandemic has highlighted the importance of accurate capture of vaccine, and vaccine component, allergy. There remains a gap in the prevalence literature from the perspective of direct primary care provider (PCP) reporting at a population level.
Source: Annals of Allergy, Asthma and Immunology - May 15, 2021 Category: Allergy & Immunology Authors: Elissa M. Abrams, Matthew Greenhawt, Marcus Shaker, Leanne Kosowan, Alexander G. Singer Source Type: research
Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents
New Brunswick, NJ (April 2, 2021) – Johnson & Johnson (the Company) has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. “The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with their education, mental health, and wellbeing,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. “It is vital that we develop vaccines for everyone, everywher...
Source: Johnson and Johnson - April 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)
Safe and effective vaccines provide the first hope for mitigating the devastating health and economic impacts resulting from coronavirus disease 2019 (COVID-19) and related public health orders. Recent case re...
Source: Allergy, Asthma and Clinical Immunology - March 15, 2021 Category: Allergy & Immunology Authors: Timothy K. Vander Leek, Edmond S. Chan, Lori Connors, Beata Derfalvi, Anne K. Ellis, Julia E. M. Upton and Elissa M. Abrams Tags: Guidelines Source Type: research
Canadian Immunization Guide: "Anaphylaxis and other acute reactions following vaccination" chapter update
CONCLUSION: The updated CIG chapter provides healthcare providers with further clarity in recognizing and managing anaphylaxis in community settings. The updated intramuscular epinephrine dosage table will aid in optimal epinephrine administration, while the revised guidance against the use of diphenhydramine hydrochloride will prevent its unnecessary stockpiling in preparation for potential mass vaccination clinics related to the coronavirus disease 2019 pandemic.PMID:33447159 | PMC:PMC7799880 | DOI:10.14745/ccdr.v46i1112a04
Source: Can Commun Dis Rep - January 15, 2021 Category: Infectious Diseases Authors: Natalie Dayneka Christina Jensen Kyla Hildebrand Source Type: research
